17
Views
1
CrossRef citations to date
0
Altmetric
Anatomical Pathology

The Symphony™ protocol for H&E staining of prostatic adenocarcinoma on needle biopsy: a multicentre analysis of 120 cases

, , , , , , & show all
Pages 450-456 | Received 26 Mar 2008, Accepted 15 Apr 2008, Published online: 06 Jul 2009
 

Summary

Aims: The diagnosis of prostate carcinoma is based on a constellation of architectural, nuclear, cytoplasmic, and ancillary features. The aim of this study was to determine if the Ventana Symphony H&E protocol can improve on the detection of prominent nucleoli in foci of prostate cancer.

Methods: One hundred and twenty cases of Gleason score 3 + 3 = 6 cancers involving 10–30% of one core were retrieved from four academic institutions and two large laboratories (20 cases per institution). The routine H&E and Symphony™ H&E protocol stained slides from the same case were reviewed centrally in a blinded fashion at the Johns Hopkins Hospital. The mean percentages of prominent nucleoli in malignant and benign glands by visual estimation were recorded for each case. After unblinding, the routine H&E slides were compared in a pair-wise t-test with the corresponding Symphony™ stained slide.

Results: Within all sites, the Symphony™ slides showed statistically significantly more prominent nucleoli in the malignant glands than the routine slides.

Conclusions: The Symphony™ H&E staining protocol consistently highlights nucleoli in cancer to a greater extent than routine H&E stains and may increase the likelihood of making a diagnosis of limited adenocarcinoma of the prostate in challenging cases.

Log in via your institution

Log in to Taylor & Francis Online

There are no offers available at the current time.

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.